Eagle Pharmaceuticals Inc (EGRX) – Strategy, SWOT and Corporate Finance Report
- Pages: 58
- Published: May 2023
- Report Code: MLPH2350231FSA
Eagle Pharmaceuticals Inc (EGRX) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Eagle Pharmaceuticals Inc (Eagle) is a specialty pharmaceutical company that offers proprietary pharmaceutical injectables in the therapy areas of critical care, oncology, and various orphan diseases. The company’s key commercial products encompass pharmaceutical injectables, including Ryanodex for exertional heatstroke; Bendeka, and Belrapzo, both for the treatment of chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin’s lymphoma (NHL). Pipeline products of the company include EP-4104 (dantrolene sodium) for exertional heat stroke (EHS) and nerve agent exposure; EA-114 (fulvestrant) for the treatment of breast cancer and Vasopressin injection for blood pressure. The company’s products cater to patients and healthcare professionals in the areas of critical care, orphan diseases, and oncology. Eagle Pharmaceuticals is headquartered in Woodcliff Lake, New Jersey, the US.
Scope
• Detailed information on Eagle Pharmaceuticals Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Eagle Pharmaceuticals Inc in the form of a SWOT analysis
• An in-depth view of the business model of Eagle Pharmaceuticals Inc including a breakdown and examination of key business segments
• News about Eagle Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Eagle Pharmaceuticals Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Eagle Pharmaceuticals Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Eagle Pharmaceuticals Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
CTI BioPharma Corp
Spectrum Pharmaceuticals Inc
Elite Laboratories Inc
Mylan Institutional LLC
Impax Laboratories Inc, 1490 Crocker Avenue, Hayward, California, United States
Endo International Plc
US WorldMeds LLC
Hikma Pharmaceuticals USA Inc
Endo International Plc
Ariad Pharmaceuticals Inc
Hikma Pharmaceuticals USA Inc
Eli Lilly and Co
Celgene Corp
Merck & Co Inc
Elite Laboratories Inc
Spectrum Pharmaceuticals Inc
Amgen Inc
Genentech USA Inc
AbbVie Inc
Regeneron Pharmaceuticals Inc
CTI BioPharma Corp
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.